Novel delivery systems of atorvastatin should be evaluated for pharmacodynamics instead of pharmacokinetics.

Sorry, there's nothing here.

Cite this paper

@article{Date2007NovelDS, title={Novel delivery systems of atorvastatin should be evaluated for pharmacodynamics instead of pharmacokinetics.}, author={Abhijit A. Date and Mangal Shailesh Nagarsenker}, journal={The Journal of pharmacy and pharmacology}, year={2007}, volume={59 11}, pages={1583-4} }